- Home
- PRTA vs BXC Comparison
PRTA vs BXC Comparison
Compare PRTA & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | BXC |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | US | US |
| Employees | N/A | 1700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 502.3M |
| IPO Year | 2013 | 2004 |
Fundamental Metrics
Financial Performance| Metric | PRTA | BXC |
|---|---|---|
| Price | $9.02 | $74.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $18.86 | ★ $88.67 |
| AVG Volume (30 Days) | ★ 364.7K | 61.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.75 | 14.84 |
| EPS | N/A | ★ 1.08 |
| Revenue | ★ $814,000.00 | N/A |
| Revenue This Year | N/A | $0.63 |
| Revenue Next Year | $1,183.79 | $3.06 |
| P/E Ratio | ★ N/A | $69.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.32 | $52.71 |
| 52 Week High | $16.67 | $91.99 |
Technical Indicators
Market Signals| Indicator | PRTA | BXC |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 50.97 |
| Support Level | $8.80 | $72.16 |
| Resistance Level | $9.23 | $75.63 |
| Average True Range (ATR) | 0.45 | 3.42 |
| MACD | 0.04 | -0.52 |
| Stochastic Oscillator | 79.21 | 49.59 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About BXC Bluelinx Holdings Inc.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.